Manchester University NHS Foundation Trust

Manchester, England M23 9LT

0 studies enrolling now · 5 studies all time

What they study most

Light Chain (AL) Amyloidosis, Low-grade Glioma, Macular Edema, Mitral Valve Regurgitation, Pediatric Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Sickle Cell Disease, Uveitis

Studies at this site

• Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY) — Running, not enrolling
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis — Stopped early
• A Study of IMR-687 in Subjects With Sickle Cell Disease — Stopped early
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial — Completed